Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the Safety and Efficacy of Analgesia-first Minimal Sedation as an Early Antihypertensive Treatment for Spontaneous Intracerebral Hemorrhage

NCT03207100 is registered in ClinicalTrials.gov with Hong Yang as lead sponsor.

NCT NCT03207100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the Safety and Efficacy of Analgesia-first Minimal Sedation as an Early Antihypertensive Treatment for Spontaneous Intracerebral Hemorrhage
Lead sponsor
Hong Yang
Phase
Not applicable
Overall status
Completed
Start date
December 6, 2017
Completion date
May 15, 2021
Enrollment
338 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure variability, duration of icu treatment and mechanical ventilation, early systolic blood pressure control rate, healthcare worker satisfaction, hematoma growth